Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Pulmonary Artery Systolic Pressure: prognostic factor in heart failure
Session:
Painel 1 - Insuficiência Cardíaca 7
Speaker:
Joana Laranjeira Correia
Congress:
CPC 2020
Topic:
D. Heart Failure
Theme:
10. Chronic Heart Failure
Subtheme:
10.2 Chronic Heart Failure – Epidemiology, Prognosis, Outcome
Session Type:
Posters
FP Number:
---
Authors:
Joana Laranjeira Correia; João Miguel Santos; Inês Pires; Luísa Gonçalves; Hugo Da Silva Antunes; António Costa; José Costa Cabral
Abstract
<p><strong>Background:</strong> Pulmonary hypertension, which precedes right heart failure (HF), is associated with an adverse prognosis. Pulmonary artery pressure (PSAP) estimation by Transthoracic Echocardiogram (TTE) seems to be an acceptable alternative to right ventricular catheterization when diagnosing this condition. The main objective of this paper was to analyze the predictive value of PSAP for the combined endpoint of mortality and readmission (D/R) at 6, 12 and 24 months after discharge in patients with HF.</p> <p><strong>Methods</strong>: A retrospective study of patients admitted in the cardiology service with acute HF was conducted. The sample was divided into 2 groups: group A (GA) with PSAP <40 mmHg vs group B (GB) with PSAP> 40 mmHg. Clinical, analytical and ultrassonagraphic parameters were evaluated in a 24-month follow-up in both groups. Statistical analysis was conducted in SPSS in order to predict the predictive value of PSAP for the combined endpoint D/R at 6, 12 and 24 months after discharge.</p> <p><strong>Results: </strong>742 patients were included in the study; 51.3% were male and the mean age was 77.66±9.926 years old. The mean ejection fraction (EF) was 49±16.35%. The mean PSAP was 47±15.5 mmHg. 71 (9.57%) patients had a previous diagnosis of chronic obstructive pulmonary disease (COPD). 25 of the patients (3.37%) died during the hospital stay. 48.95% and 54.81% of the patients achieved the combined endpoint D / R, respectively, at 12 months and 24 months after discharge. The following Kaplan-Meier survival curves were determined for the combinated endpoint D/R for GA and GB: 6 Months - X<sup>2 </sup>6.119 (p=.013); 12 Months - X<sup>2</sup> 8.293(p=.004); 24 Months - X<sup>2 </sup>9.457(p=.002). The PSAP value demonstrated to be an independent variable in predicting the 24-month combinated endpoint (HR:1.015 p=.05) after adjusting for other prognostic variables such as age, diabetes melittus, chronic kidney disease, COPD, systolic blood pressure, BNP value and EF.</p> <p><strong>Conclusion: </strong>In this sample, higher PSAP values ??demonstrated to be associated with worse prognosis, with a significant correlation in both short and long-term mortality, since GB had a worse outcome. PSAP value proved to be an useful indicator for the combined endpoint of D / R at 6, 12 and 24 months after discharge.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site